C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 231/54 (2006.01) A61K 31/416 (2006.01) A61K 31/422 (2006.01) A61P 3/00 (2006.01) A61P 25/00 (2006.01) C07D 401/06 (2006.01) C07D 403/04 (2006.01) C07D 413/04 (2006.01) C07D 413/12 (2006.01) C07D 417/04 (2006.01)
Patent
CA 2668491
The present invention relates to novel cannabinoid receptor modulators, in particular cannabinoid 1 (CB1) or cannabinoid 2 (CB2) receptor modulators, and uses thereof for treating diseases, conditions and/or disorders modulated by a cannabinoid receptor (such as pain, neurodegenative disorders, eating disorders, weight loss or control, and obesity).
La présente invention concerne de nouveaux modulateurs de récepteurs cannabinoïdes, en particulier des modulateurs de récepteurs cannabinoïdes 1 (CB1) ou cannabinoïdes 2 (CB2), et des utilisations de ceux-ci pour traiter des maladies, des états et/ou des troubles modulés par un récepteur cannabinoïde (tels que la douleur, des troubles neurodégénératifs, des troubles de l'alimentation, une perte de poids ou un contrôle de poids et l'obésité).
Balasubramanian Gopalan
Gullapalli Srinivas
Joshi Neelima Khairatkar
Karnik Pallavi V.
Muthuppalantappan Meyyappan
Auerbach Jonathan N.
Glenmark Pharmaceuticals S.a.
LandOfFree
Novel cannabinoid receptor ligands, pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel cannabinoid receptor ligands, pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel cannabinoid receptor ligands, pharmaceutical... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1498350